BRÈVE

sur LUCIBEL (EPA:ALUCI)

Michèle Pelletier Aouizérate honored at the Health and Medical Aesthetics Awards

Graphique de l'évolution du cours de l'action LUCIBEL (EPA:ALUCI).

On December 14, 2024, Michèle Pelletier Aouizérate received the Research and Innovation Prize at the Health and Medical Aesthetics Awards in Paris. A dermatologist specializing in photobiomodulation, her research over the past 20 years has had a significant impact, particularly in the treatment of respiratory problems linked to COVID-19.

The event, which brought together more than 700 participants, rewarded her commitment with a pioneering publication in 2021. Founder of the European LED Academy, she has promoted the international development of this technology in dermatology.

Lucibel, which benefits from his expertise, continues to rely on his innovations, particularly in the OVE range. Frédéric Granotier, President of Lucibel, praised his contribution to the company's strategy in photobiomodulation.

R. H.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de LUCIBEL